Yes, the FDA did just slap down PTC’s Duchenne MD drug for the third time
Whatever last shred of hope remained that PTC could turn things around and win a miracle approval at the FDA for their Duchenne muscular dystrophy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
